Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cin-102 (1 trial)
vasopressin (vasostrict) (1 trial)
Gastroparesis (Phase 2)
Trials (2 total)
Trial APIs (2 total)